US 10813918
Use of Gaboxadol in the treatment of diabetes and related conditions
granted A61KA61K31/155A61K31/437
Quick answer
US patent 10813918 (Use of Gaboxadol in the treatment of diabetes and related conditions) held by OVID THERAPEUTICS INC. expires Mon Oct 22 2040 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- OVID THERAPEUTICS INC.
- Grant date
- Tue Oct 27 2020 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Oct 22 2040 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 15
- CPC classes
- A61K, A61K31/155, A61K31/437, A61K31/4985, A61K45/06